Clinical trial
Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis
NCT00447837 · Naryx Pharma, Industry · Completed
Key facts
| NCT number | NCT00447837 |
|---|---|
| Title | Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis |
| Official title | A Phase 2, Double-Blind, Placebo-Controlled, Multi-Center, Randomized Study Evaluating the Safety and Efficacy of SPRC-AB01, Tobramycin Solution for Nasal Inhalation, in Post-Surgical Subjects With Chronic Sinusitis |
| Lead sponsor | Naryx Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Sinusitis |
| Intervention type | Drug |
| Interventions | SPRC-AB01 |
| Enrollment | 180 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Mar 15, 2007 |
| Last update posted | Mar 17, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: